UK markets closed

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.57000.0000 (0.00%)
As of 10:04AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,380
1,380
375
0
0
Cost of revenue
1,260
1,260
20
0
-
Gross profit
120
120
355
0
-
Operating expenses
Research development
84,326
84,326
91,239
52,708
57,995
Selling general and administrative
83,413
83,413
68,761
54,228
24,302
Total operating expenses
167,739
167,739
160,000
106,936
82,297
Operating income or loss
-167,619
-167,619
-159,645
-106,936
-82,297
Interest expense
13,314
13,314
8,213
40
27
Total other income/expenses net
-3,769
-3,769
-427
-
155
Income before tax
-179,053
-179,053
-165,757
-106,932
-82,169
Income from continuing operations
-179,053
-179,053
-165,757
-106,932
-82,169
Net income
-179,053
-179,053
-165,757
-106,931
-82,169
Net income available to common shareholders
-179,053
-179,053
-165,757
-106,931
-82,169
Basic EPS
-7.36
-6.15
-5.92
-4.05
-3.79
Diluted EPS
-7.36
-6.15
-5.92
-4.05
-3.79
Basic average shares
28,787
29,129
28,015
26,373
21,683
Diluted average shares
28,787
29,129
28,015
26,373
21,683